Related Experiment Video
Updated: Jun 4, 2026

The Combined Use of Transcranial Direct Current Stimulation and Robotic Therapy for the Upper Limb
Published on: September 23, 2018
Rehab-DRLX: explainable neurorehabilitation prognosis using deep reinforcement learning and transformer-based models
Hadeel Alsolai1, Shakir Khan2, Rakesh Kumar Mahendran3
1Department of Information Systems, College of Computer and Information Sciences, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
None:
Neurorehabilitation poses a crucial problem in clinical recovery tasks, particularly for individuals with poor motor functions and neurological impairments, and problems in activities of daily living (ADL). To resolve this, we design a novel model, Rehab-DRLX, with a hybrid deep learning (HDL) framework that combines deep reinforcement learning (DRL) with an explainable transformer model to provide interpretable, accurate prognostic results. The propounded model is designed to effectively process the multimodal data inputs, which include clinical records, sensor-entrenched motion data, and neuroimaging, along with time-dependent recovery patterns from its reinforced representation learning (RRL) module. The RRL module employs a convolutional neural network (CNN) within the DRL agent, which performs spatiotemporal feature encoding and dynamically recovers a policy from its reward-guided learning method. To ensure interpretability, the explainable prognosis transformer (XPT) is utilized, which contains clinical contextual positional encoding and a hierarchical attention mechanism to enable transparent and reliable decision-making. This duality in the Rehab-DRLX architecture enables effective forecasting of the recovery outcomes, including functional independence probability, with both interpretability and accuracy, addressing the drawbacks of conventional black box prognosis tools. The experimental results of Rehab-DRLX show the noteworthy improvements in metrics such as accuracy (94.6%), F1-score (0.93), root mean square (RMSE) (0.082), and mean absolute error (MAE) (0.061) compared to existing studies. The ablation studies reveal the significant contribution of every architectural component and its overall performance. The results show the practical viability of Rehab-DRLX, which not only improves decision-making but also builds clinical trust through explainable insights.
